Dell Med maternal fetal medicine specialist Kenneth Moise, M.D, is leading a study into nipocalimab, a new investigational drug that’s showing promise in treating a rare blood disease in babies. It could help prevent anemia and cut down on the need for blood transfusions during pregnancy, making treatment safer and easier.
The Texas Health Catalyst Roundup and Rodeo presented finalist teams of UT collaborators who participated in the latest Texas Health Catalyst application cycle.
Faculty and learners from all health professions across the U.S. will soon have access to an innovative curriculum addressing best practices in caring for those with Alzheimer’s and other dementias.
At the inaugural UT System AI Symposium in Health Care, Dean Claudia Lucchinetti joined experts to discuss the statewide expertise and opportunities to leverage artificial intelligence and machine learning to improve health and care.
This year’s Resident and Fellow Research Day highlighted quality improvement, clinical vignettes and research within graduate medical education.